ADSL and cystic fibrosis: This design has been modified with an AAAG linker and extended to a series of other AMPs including HB43 and Bac8c, similarly demonstrating NE-reversible reductions in antimicrobial activity against P. aeruginosa, with both purified enzyme and that contained in CF bronchoalveolar lavage fluid.